Title |
Systemic Injections of Cannabidiol Enhance Acetylcholine Levels from Basal Forebrain in Rats
|
---|---|
Published in |
Neurochemical Research, June 2018
|
DOI | 10.1007/s11064-018-2565-0 |
Pubmed ID | |
Authors |
Eric Murillo-Rodríguez, Gloria Arankowsky-Sandoval, Nuno Barbosa Rocha, Rodrigo Peniche-Amante, André Barciela Veras, Sérgio Machado, Henning Budde |
Abstract |
Cannabis sativa is a plant that contains more than 500 components, of which the most studied are Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD). Several studies have indicated that CBD displays neurobiological effects, including wake promotion. Moreover, experimental evidence has shown that injections of CBD enhance wake-related compounds, such as monoamines (dopamine, serotonin, epinephrine, and norepinephrine). However, no clear evidence is available regarding the effects of CBD on additional wake-related neurochemicals such as acetylcholine (ACh). Here, we demonstrate that systemic injections of CBD (0, 5, 10 or 30 mg/kg, i.p.) at the beginning of the lights-on period, increase the extracellular levels of ACh collected from the basal forebrain and measured by microdialysis and HPLC means. Moreover, the time course effects on the contents of ACh were present 5 h post-injection of CBD. Altogether, these data demonstrate that CBD increases ACh levels in a brain region related to wake control. This study is the first to show the effects of ACh levels in CBD-treated rats and suggests that the basal forebrain might be a site of action of CBD for wakefulness modulation. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 2 | 29% |
Japan | 1 | 14% |
United States | 1 | 14% |
Unknown | 3 | 43% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 71% |
Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Science communicators (journalists, bloggers, editors) | 1 | 14% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 53 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 14 | 26% |
Student > Master | 8 | 15% |
Student > Doctoral Student | 3 | 6% |
Student > Ph. D. Student | 3 | 6% |
Student > Bachelor | 3 | 6% |
Other | 4 | 8% |
Unknown | 18 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 9% |
Biochemistry, Genetics and Molecular Biology | 5 | 9% |
Agricultural and Biological Sciences | 5 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 8% |
Neuroscience | 4 | 8% |
Other | 9 | 17% |
Unknown | 21 | 40% |